LATEST IN CELL THERAPY BIOMANUFACTURING NEWS

Gencure, a subsidiary of BioBridge Global, offers a variety of ways for you to stay connected with us. You can read our latest industry new here. Or, for the social media enthusiast, the BioBridge family is known as “Connect for Life,” and can be found on Facebook, Twitter, LinkedIn and YouTube.

separator
gencure_biomanufacturing_center

RoosterBio and GenCure Sign Multiple Agreements to Advance Regenerative Medicine Startups

April 10, 2019 Multiple deals signed that leverage Plug&Play cGMP hMSC systems across med tech and synthetic biology segments of the regenerative medicine industry. RoosterBio Inc. and GenCure, both regenerative medicine manufacturing technology leaders, have locked into multiple agreements to help companies advance their innovations to clinical testing more rapidly than ever before. Companies across […]

Read More

G-CON Manufacturing to supply PODs for GenCure BioManufacturing Center

March 29, 2019 GenCure has selected G-CON Manufacturing, a major producer of prefabricated, flexible cleanroom solutions, for its new multi-product cellular therapy facility. The new facility, which will anchor the VelocityTX innovation center in San Antonio, will expand capabilities of the GenCure BioManufacturing Center, providing new state-of-the-art manufacturing capabilities to support clinical cell therapy trials. […]

Read More
gencure_velocity_release

BioBridge Global announces plans for GenCure biomanufacturing facilities at VelocityTX Innovation Center planned for redeveloped Merchant’s Ice complex

San Antonio-based BioBridge Global was announced today as the anchor tenant at the groundbreaking for the VelocityTX innovation center, located in the redeveloped Merchant’s Ice complex at 1304 and 1305 East Houston St. BioBridge Global will lease 21,000 square feet to establish the second phase of its GenCure Biomanufacturing program, initially launched in February of […]

Read More